Stocks
Integra LifeSciences Holdings Corporation (IART) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 59.1% | 121.1% | 193.5% | 214.9% | 93.8% | 152.2% | |||
| Changes by years, y/y, % | -41pp | +62pp | +72pp | +21pp | -121pp | -1.4% | |||
Integra LifeSciences Holdings Corporation. R&D/CAPEX, %
Integra LifeSciences Holdings Corporation. R&D/CAPEX, changes, pp
Integra LifeSciences Holdings Corporation (IART) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 195.0% | 171.0% | 203.4% | 99.1% | 174.4% | 152.2% | ||
| Changes by years, y/y, % | +24pp | -101pp | -67pp | -86pp | -21pp | |||
| Changes by quarters, q/q, % | +10pp | -24pp | +32pp | -104pp | +75pp | |||
